treatment with bilastine plus montelukast over 4 weeks does not consistently produce further improvements in SARC symptoms and AQLQ beyond those provided by either agents alone. Thus, there is no benefit of using bilastine plus montelukast to provide relief of SARC symptoms in partially controlled, mild-to-moderate asthma patients
Concomitant Bilastine and Montelukast as Additive Therapy for Seasonal Allergic Rhinoconjunctivits and Mild-to-Moderate Asthma. The SKY Study / Lavorini, Federico; Matucci, Andrea; Rossi, Oliviero; Pistolesi, Massimo. - In: ALLERGY. - ISSN 0105-4538. - ELETTRONICO. - (2019), pp. 1-4. [10.1111/all.14007]
Concomitant Bilastine and Montelukast as Additive Therapy for Seasonal Allergic Rhinoconjunctivits and Mild-to-Moderate Asthma. The SKY Study
Lavorini, Federico
;Matucci, Andrea;ROSSI, OLIVIERO;Pistolesi, Massimo
2019
Abstract
treatment with bilastine plus montelukast over 4 weeks does not consistently produce further improvements in SARC symptoms and AQLQ beyond those provided by either agents alone. Thus, there is no benefit of using bilastine plus montelukast to provide relief of SARC symptoms in partially controlled, mild-to-moderate asthma patientsFile | Dimensione | Formato | |
---|---|---|---|
Lavorini_et_al-2019-Allergy.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
196.04 kB
Formato
Adobe PDF
|
196.04 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.